Eva Lonn

38.4k total citations · 6 hit papers
193 papers, 15.2k citations indexed

About

Eva Lonn is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eva Lonn has authored 193 papers receiving a total of 15.2k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Cardiology and Cardiovascular Medicine, 48 papers in Surgery and 45 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eva Lonn's work include Blood Pressure and Hypertension Studies (63 papers), Heart Failure Treatment and Management (29 papers) and Cardiovascular Health and Disease Prevention (29 papers). Eva Lonn is often cited by papers focused on Blood Pressure and Hypertension Studies (63 papers), Heart Failure Treatment and Management (29 papers) and Cardiovascular Health and Disease Prevention (29 papers). Eva Lonn collaborates with scholars based in Canada, United States and Germany. Eva Lonn's co-authors include Salim Yusuf, Qilong Yi, Koon Teo, Hertzel C. Gerstein, Jackie Bosch, Sonia S. Anand, Matthew McQueen, Samer S. Najjar, Monica Gianni and Christopher M. Rembold and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Eva Lonn

189 papers receiving 14.5k citations

Hit Papers

Use of Carotid Ultrasound to Identify Subclinical Vascula... 1999 2026 2008 2017 2008 2006 2006 2000 1999 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular Medicine
    2008 1.8k citations Eva Lonn et al. profile →
  2. Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
    2006 1.2k citations Eva Lonn profile →
  3. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review
    2006 1.0k citations Monica Gianni, Eva Lonn et al. European Heart Journal profile →
  4. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)
    2000 842 citations Sonia S. Anand, Salim Yusuf et al. The Lancet profile →
  5. Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
    1999 727 citations John W. Eikelboom, Eva Lonn et al. Annals of Internal Medicine profile →
  6. Effects of Ramipril and Vitamin E on Atherosclerosis
    2001 534 citations Eva Lonn, Salim Yusuf et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Lonn Canada 56 8.1k 3.1k 2.5k 2.5k 1.8k 193 15.2k
Wendy S. Post United States 68 9.6k 1.2× 3.4k 1.1× 2.7k 1.1× 1.3k 0.5× 2.5k 1.4× 436 20.1k
Jacqueline C.M. Witteman Netherlands 69 5.4k 0.7× 2.2k 0.7× 2.1k 0.9× 1.1k 0.5× 2.3k 1.3× 170 16.2k
Gianni Tognoni Italy 76 11.6k 1.4× 4.1k 1.3× 2.8k 1.1× 1.6k 0.6× 3.8k 2.1× 263 23.8k
Halit Silbershatz United States 24 8.4k 1.0× 3.4k 1.1× 3.1k 1.2× 857 0.3× 1.5k 0.8× 32 15.9k
James H. Stein United States 61 7.6k 0.9× 4.1k 1.3× 2.8k 1.1× 787 0.3× 3.0k 1.7× 345 18.2k
Mark J. Sarnak United States 81 9.0k 1.1× 3.9k 1.3× 2.7k 1.1× 1.1k 0.4× 4.2k 2.4× 288 27.9k
Joachim H. Ix United States 70 4.7k 0.6× 3.1k 1.0× 2.1k 0.8× 1.0k 0.4× 3.1k 1.8× 473 17.7k
Michael E. Farkouh United States 60 6.8k 0.8× 4.9k 1.6× 2.0k 0.8× 1.1k 0.5× 2.4k 1.4× 342 15.2k
Giuseppe Schillaci Italy 62 11.7k 1.4× 2.7k 0.9× 2.3k 0.9× 609 0.2× 1.6k 0.9× 217 16.4k
Alejandro Castro Spain 18 5.0k 0.6× 3.0k 1.0× 2.8k 1.1× 863 0.3× 3.1k 1.8× 62 20.5k

Countries citing papers authored by Eva Lonn

Since Specialization
Citations

This map shows the geographic impact of Eva Lonn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Lonn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Lonn more than expected).

Fields of papers citing papers by Eva Lonn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Lonn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Lonn. The network helps show where Eva Lonn may publish in the future.

Co-authorship network of co-authors of Eva Lonn

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Lonn. A scholar is included among the top collaborators of Eva Lonn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Lonn. Eva Lonn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Straburzyńska‐Migaj, Ewa, Michele Senni, Rolf Wachter, et al.. (2023). Early Initiation of Sacubitril/Valsartan in Patients With Acute Heart Failure and Renal Dysfunction: An Analysis of the TRANSITION Study. Journal of Cardiac Failure. 30(3). 425–435. 4 indexed citations
2.
Haring, Bernhard, Helmut Schumacher, Giuseppe Mancia, et al.. (2023). Triglyceride-glucose index, low-density lipoprotein levels, and cardiovascular outcomes in chronic stable cardiovascular disease: results from the ONTARGET and TRANSCEND trials. European Journal of Preventive Cardiology. 31(3). 311–319. 13 indexed citations
3.
Bosch, Jackie, Eva Lonn, Gilles R. Dagenais, et al.. (2021). Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial. Stroke. 52(8). 2494–2501. 15 indexed citations
4.
Böhm, Michael, Helmut Schumacher, Koon Teo, et al.. (2019). Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk. European Heart Journal. 40(25). 2032–2043. 42 indexed citations
5.
Ridker, Paul M., Eva Lonn, Nina P. Paynter, Robert J. Glynn, & Salim Yusuf. (2017). Primary Prevention With Statin Therapy in the Elderly. Circulation. 135(20). 1979–1981. 89 indexed citations
6.
Verma, Subodh, et al.. (2017). Association of Apolipoproteins B and A-1 With Markers of Vascular Health or Cardiovascular Events. Canadian Journal of Cardiology. 33(10). 1305–1311. 16 indexed citations
7.
Mancini, G.B. John, Alice Cheng, Kim A. Connelly, et al.. (2016). Diabetes for Cardiologists: Practical Issues in Diagnosis and Management. Canadian Journal of Cardiology. 33(3). 366–377. 20 indexed citations
8.
Yusuf, Salim, Amir Attaran, Jackie Bosch, et al.. (2013). Combination Pharmacotherapy to Prevent Cardiovascular Disease: Present Status and Challenges. SSRN Electronic Journal. 18 indexed citations
9.
Teoh, Hwee, Jean‐Pierre Després, Robert Dufour, et al.. (2013). Identification and Management of Patients at Elevated Cardiometabolic Risk in Canadian Primary Care: How Well Are We Doing?. Canadian Journal of Cardiology. 29(8). 960–968. 14 indexed citations
10.
Kratz, Mario, Helmut Schumacher, Karen Sliwa, et al.. (2013). Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients. European Journal of Preventive Cardiology. 21(3). 272–280. 13 indexed citations
11.
Gao, Peggy, et al.. (2010). Abstract 12667: Heart Rate is associated with Increased Risk of Major Cardiovascular Events, Cardiovascular and All-Cause Death in Patients with Stable Chronic Cardiovascular Disease - An Analysis of ONTARGET/ TRANSCEND. Circulation. 10 indexed citations
12.
Lonn, Eva, Hertzel C. Gerstein, Patrick Sheridan, et al.. (2009). Effect of Ramipril and of Rosiglitazone on Carotid Intima-Media Thickness in People With Impaired Glucose Tolerance or Impaired Fasting Glucose. Journal of the American College of Cardiology. 53(22). 2028–2035. 44 indexed citations
13.
Morrison, Katherine M., Leanne Dyal, William T. Conner, et al.. (2009). Cardiovascular risk factors and non-invasive assessment of subclinical atherosclerosis in youth. Atherosclerosis. 208(2). 501–505. 62 indexed citations
14.
Grewal, Jasmine, Robert S. McKelvie, Eva Lonn, et al.. (2008). BNP and NT-proBNP Predict Echocardiographic Severity of Diastolic Dysfunction. European Journal of Heart Failure. 10(3). 252–259. 101 indexed citations
15.
Arnold, J. Malcolm O., David Fitchett, Jonathan G. Howlett, Eva Lonn, & Jean‐Claude Tardif. (2008). Resting heart rate: A modifiable prognostic indicator of cardiovascular risk and outcomes?. Canadian Journal of Cardiology. 24. 3A–15A. 61 indexed citations
16.
Mann, Johannes F.E., Eva Lonn, Qilong Yi, et al.. (2004). Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: Results of the HOPE Study. Kidney International. 65(4). 1375–1380. 92 indexed citations
17.
Anderson, Todd J., Kathy Hildebrand, H. Conradson, et al.. (2003). The fate of endothelial function testing: rationale and design of the Firefighters And Their Endothelium (FATE) study.. PubMed. 19(1). 61–6. 31 indexed citations
18.
Anand, Sonia S., Salim Yusuf, Ruby Jacobs, et al.. (2001). Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP). The Lancet. 358(9288). 1147–1153. 237 indexed citations
19.
Eikelboom, John W., Eva Lonn, Jacques Genest, Graeme J. Hankey, & Salim Yusuf. (1999). Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence. Annals of Internal Medicine. 131(5). 363–375. 727 indexed citations breakdown →
20.
Ryan, Linda, et al.. (1992). In vitro high resolution intravascular imaging in muscular and elastic arteries. Journal of the American College of Cardiology. 20(1). 153–160. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy S. Post Breakdown of academic impact, for papers by Jacqueline C.M. Witteman Breakdown of academic impact, for papers by Gianni Tognoni Breakdown of academic impact, for papers by Halit Silbershatz Breakdown of academic impact, for papers by James H. Stein Breakdown of academic impact, for papers by Mark J. Sarnak Breakdown of academic impact, for papers by Joachim H. Ix Breakdown of academic impact, for papers by Michael E. Farkouh Breakdown of academic impact, for papers by Giuseppe Schillaci Breakdown of academic impact, for papers by Alejandro Castro
Rankless by CCL
2026